OTHER GROUP COMPANIES
market

Dr Reddys Laboratories standalone net loss at Rs.5.70 crore in Q4FY16 against net profit of Rs. 236.80 crore in Q4FY15

The company’s standalone revenue stood at Rs. 2,356.80 crore, down 12.34% yoy and 2.96% qoq.

May 12, 2016 1:38 IST | India Infoline News Service
Dr Reddys Laboratories Ltd, Hyderabad's multinational pharmaceutical company, reported standalone net loss of Rs.5.70 crore for the quarter ended March 31, 2016. However, it had reported net profit of Rs.571.42 crore in the corresponding quarter of the previous year and Rs. 236.80 crore in the preceding quarter. The company’s standalone revenue stood at Rs. 2,356.80 crore, down 12.34% yoy and 2.96% qoq.

Its standalone core operating profit of Rs. 342.10 crore for the quarter, declined by 54.75% yoy and 19.79% qoq. Operating profit margin for the current quarter at 14.52% contracted by 1360 bps yoy and 304 bps qoq.

For the year ended March 31, 2016, the company reported standalone net profit of Rs. 1,354.47 crore, declining by 19.35% yoy. Its standalone revenue for the period stood at Rs. 10,207.70 crore, registering growth of 1.96% yoy.

Dr Reddys Laboratories Ltd's core operating profit stood at Rs. 2,404 crore, recording growth of 0.54% yoy. Operating margin for the current period at 21.86% contracted by 202 bps yoy.

Corporate Action: Dr Reddys Laboratories' board of directors at its meeting held on May 12, 2016 have recommended a final dividend of Rs.20/- (400%) per equity share of Rs.5/- face value, for the financial year 2015-16. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 1, 2016.


Stock Commentary:

Dr Reddys Laboratories Ltd is currently trading at Rs. 2918, up by 48.8 points or 1.7% from its previous closing of Rs. 2869.2 on the BSE.

The scrip opened at Rs. 2845 and has touched a high and low of Rs. 2964.8 and Rs. 2845 respectively. So far 1173028(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 48950.75 crore.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 2958 and Rs. 2825 respectively.

The promoters holding in the company stood at 25.58 % while Institutions and Non-Institutions held 42.02 % and 32.4 % respectively.


OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity